TrimRx and GLP-1 weight loss claims: what the science says

What did @katttee_vsg actually say?

She said one thing loudly and clearly: a company called TrimRx clipped her weight loss surgery transformation videos without permission and used them to sell weight loss drugs. She had nothing to do with it. "I am not associated with Trimarex in any being," she said, and spent the video trying to reach the 10% of viewers who might actually buy based on fake endorsements.

She also made a broader point that deserves attention on its own merits: her body transformation took years, not 30 days. She was specifically pushing back on the framing these ads use, where dramatic before-and-after images get paired with supplement or drug claims and a suspiciously short timeline. That is not a minor side note. It is the core deception that makes this kind of advertising work.

To be fair to the audience: she acknowledged most followers already know her story. This video was aimed at newcomers and at documenting the pattern publicly so people see the comments and catch on.

Does the science back this up?

On the main claim, yes, completely. Unauthorized use of personal content to market health products is both legally prohibited and clinically dangerous. The FTC has repeatedly warned that fake endorsements and fabricated testimonials in weight loss advertising cause real financial and physical harm to consumers.

Her point about timeline is also well-supported. Meaningful, sustained weight loss after bariatric surgery typically unfolds over 12 to 24 months. A 2018 study by Thereaux et al. in JAMA Surgery followed patients for five years after sleeve gastrectomy and found that maximum weight loss occurred around 12 to 18 months post-operation, with some regain common after that. No smoothie, detox, or over-the-counter supplement produces results comparable to surgical or GLP-1-based interventions, and even those take months, not weeks.

The FTC's 2022 final rule updates on endorsements and testimonials explicitly prohibit advertisers from using results that are not typical without clear disclosure, and a stolen transformation video from a surgery patient is about as non-typical as it gets for a supplement ad.

What did they get wrong (or right)?

She got the core of this right. There is nothing scientifically dubious in what she said. She did not overclaim about her own results, did not recommend a product, and did not suggest surgery is easy or fast. That restraint is worth noting because this category of content is saturated with exactly the opposite.

One minor imprecision: she repeatedly called the company "Trimarex" when the hashtag and caption reference "TrimRx." TrimRx is an actual regulated telehealth company operating in the GLP-1 space. Whether the ads she is describing are truly from TrimRx the company, a copycat using the name, or a bad actor piggybacking on the branding is not clear from the video alone. That distinction matters legally and practically for anyone trying to report the content.

She also said "I don't think people are this naive" about 30-day transformation claims. Research suggests more people are susceptible than she thinks. A 2020 study by Evers et al. in Appetite found that exposure to before-and-after testimonials significantly increased purchase intention for diet products, even among participants who self-reported skepticism. Perceived authenticity of the image, not the logic of the claim, drove decisions.

What should you actually know?

If you saw an ad using someone's transformation and it drove you to buy something, you were probably targeted deliberately. This is not random content theft. Advertisers in the weight loss space specifically seek out high-engagement organic transformation content because it converts better than produced ads. A real person's real journey carries emotional weight that stock imagery does not.

GLP-1 medications like semaglutide and tirzepatide do produce meaningful weight loss results in clinical trials. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% body weight reduction over 72 weeks in adults with obesity. That is significant. But it is 72 weeks, not 30 days, requires a prescription, involves side effect management, and is nothing like a smoothie.

Sleeve gastrectomy, which is what this creator had, produces different physiological changes than GLP-1 therapy. Using her results to sell a drug, a supplement, or anything else is not just ethically wrong. It is a fundamental mismatch of mechanism and timeline.

If you encounter content like this, the FTC complaint portal and the platform's ad reporting tools are both worth using. One takedown followed by re-upload with different audio, exactly what she described, is a documented evasion tactic that platforms have been slow to address systematically.